Day: February 14, 2024

Certified Proven Reserve PV10 Value Up 135% HOUSTON, Feb. 14, 2024 (GLOBE NEWSWIRE) — Equus Total Return, Inc. (NYSE: EQS) (“Equus”) today announced that its wholly-owned subsidiary Morgan E&P, LLC (“Morgan”), has received from Cawley, Gillespie & Associates, Inc. (“CG&A”) an updated reserve estimate as of January 1, 2024. Morgan continues to acquire mineral rights in the Bakken/Three Forks formation in the Williston Basin of North Dakota, and on December 18, 2023, announced an increase in its acreage in this area from 4,747.52 net acres to 5,976.84 net acres, an increase of 1,229.32 net acres, or approximately 25.9%. Morgan engaged the petroleum engineering firm of CG&A to review and provide an updated reserve analysis of this asset using the December 29, 2023 NYMEX strip pricing. Using...

Initial indications target fibromyalgia and chronic pain Loaded and encapsulated drug maintains structural stability as implantable treatment SARASOTA, FL, Feb. 14, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today provided a positive update on SP-26, its novel time-released, dose-controlled formulation of ketamine initially targeted for fibromyalgia. A pre-clinical research study is underway involving analytical testing services and small batch proof-of-concept extrusion trials to determine drug release and stability. In recent testing, SP-26 polymer implants were blended with ketamine hydrochloride (ketamine HCL) in two...

BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting business through its variable interest entity in China, today announced that TRX HongKong Investment Limited (“TRX HongKong”), a wholly-owned subsidiary of the Company, has entered into a sale and purchase agreement (the “SPA”) to acquire Peak Consulting Services Limited (the “Target”) from Yuefu Company Limited (the “Vendor”), the sole shareholder of the Target. The Target is a licensed insurance brokerage in Hong Kong. This strategic acquisition represents a milestone in the Company’s business to expand into the Hong Kong insurance brokerage market. Pursuant to the SPA, the proposed acquisition (the “Acquisition”) is conditioned upon, among other things, the completion...